These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 14581338)
1. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance. Freitas S; Moore DH; Michael H; Kelley MR Clin Cancer Res; 2003 Oct; 9(13):4689-94. PubMed ID: 14581338 [TBL] [Abstract][Full Text] [Related]
2. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers. Moore DH; Michael H; Tritt R; Parsons SH; Kelley MR Clin Cancer Res; 2000 Feb; 6(2):602-9. PubMed ID: 10690545 [TBL] [Abstract][Full Text] [Related]
3. Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas. Tanner B; Grimme S; Schiffer I; Heimerdinger C; Schmidt M; Dutkowski P; Neubert S; Oesch F; Franzen A; Kölbl H; Fritz G; Kaina B; Hengstler JG Gynecol Oncol; 2004 Feb; 92(2):568-77. PubMed ID: 14766249 [TBL] [Abstract][Full Text] [Related]
4. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor. Zhang Y; Wang J; Xiang D; Wang D; Xin X Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261 [TBL] [Abstract][Full Text] [Related]
5. Differential cellular and subcellular expression of the human multifunctional apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme. Duguid JR; Eble JN; Wilson TM; Kelley MR Cancer Res; 1995 Dec; 55(24):6097-102. PubMed ID: 8521399 [TBL] [Abstract][Full Text] [Related]
6. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790 [TBL] [Abstract][Full Text] [Related]
7. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Xu Y; Moore DH; Broshears J; Liu L; Wilson TM; Kelley MR Anticancer Res; 1997; 17(5B):3713-19. PubMed ID: 9427767 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of human apurinic/apyrimidinic endonuclease (APE/Ref-1) expression in rectal cancer treated with preoperative radiochemotherapy. Kim JS; Kim JM; Liang ZL; Jang JY; Kim S; Huh GJ; Kim KH; Cho MJ Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):130-7. PubMed ID: 21075552 [TBL] [Abstract][Full Text] [Related]
9. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of APE/ref-1 in recurrence stage I, non small cell lung cancer. Kang MW; Kang SK; Choi S; Lee CS; Jeon BH; Lim SP Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):36-41. PubMed ID: 22371940 [TBL] [Abstract][Full Text] [Related]
11. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035 [TBL] [Abstract][Full Text] [Related]
12. Oxidative cellular damage and the reduction of APE/Ref-1 expression after experimental traumatic brain injury. Lewén A; Sugawara T; Gasche Y; Fujimura M; Chan PH Neurobiol Dis; 2001 Jun; 8(3):380-90. PubMed ID: 11447995 [TBL] [Abstract][Full Text] [Related]
13. Early decrease of apurinic/apyrimidinic endonuclease expression after transient focal cerebral ischemia in mice. Fujimura M; Morita-Fujimura Y; Kawase M; Chan PH J Cereb Blood Flow Metab; 1999 May; 19(5):495-501. PubMed ID: 10326716 [TBL] [Abstract][Full Text] [Related]
14. Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas. Puglisi F; Barbone F; Tell G; Aprile G; Pertoldi B; Raiti C; Kelley MR; Damante G; Sobrero A; Beltrami CA; Di Loreto C Oncol Rep; 2002; 9(1):11-7. PubMed ID: 11748448 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the DNA repair protein APE/REF-1 by CKII affects redox regulation of AP-1. Fritz G; Kaina B Oncogene; 1999 Jan; 18(4):1033-40. PubMed ID: 10023679 [TBL] [Abstract][Full Text] [Related]
16. Decisive role of apurinic/apyrimidinic endonuclease/Ref-1 in initiation of cell death. Cho KJ; Kim HJ; Park SC; Kim HW; Kim GW Mol Cell Neurosci; 2010 Nov; 45(3):267-76. PubMed ID: 20637286 [TBL] [Abstract][Full Text] [Related]
17. Altered level of apurinic/apyrimidinic endonuclease/redox factor-1 (APE/REF-1) mRNA in the hippocampus of ovariectomized rats treated by raloxifene against kainic acid. Yalcin A; Kanit L; Durmaz G; Sargin S; Terek CH; Tanyolac B Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):611-4. PubMed ID: 16120186 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. Robertson KA; Hill DP; Xu Y; Liu L; Van Epps S; Hockenbery DM; Park JR; Wilson TM; Kelley MR Cell Growth Differ; 1997 Apr; 8(4):443-9. PubMed ID: 9101090 [TBL] [Abstract][Full Text] [Related]
19. Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells. Yang S; Misner BJ; Chiu RJ; Meyskens FL Carcinogenesis; 2007 Nov; 28(11):2382-90. PubMed ID: 17566060 [TBL] [Abstract][Full Text] [Related]
20. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance. Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]